Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

U.S. patent covers DLK gene

Feb. 13, 1997

PPL reports progress in transgenic cow program

Feb. 13, 1997

AGE inhibitors reported by Kissei

Feb. 13, 1997

NexMed licenses alprostadil cream

Feb. 12, 1997

Menorest approved in 29 markets

Feb. 12, 1997

AGE inhibitors reported by Alteon

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Selection Therapeutics identifies new Kv1.3 blockers
BioWorld Science
Selection Therapeutics GmbH has discovered new potassium voltage-gated channel subfamily A member 3 (KCNA3; Kv1.3) blockers potentially useful for the treatment...
Ignis Therapeutics synthesizes new muscarinic M4 receptor PAMs
BioWorld Science
Ignis Therapeutics (Suzhou) Co. Ltd. has patented new muscarinic M4 receptor positive allosteric modulators (PAMs) potentially useful for the treatment of...